Limited-Time September Offer: Try 7 Days for Free

Gilead Sciences (GIS.DE) Stock Price

€99.72 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    6
  • Fundamental

    8
  • Technical

    6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Gilead Sciences, AI stock picks, stock alerts and much more.

Sign up

GIS.DE AI Stock Analysis

AI stock analysis for GIS.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Gilead Sciences (GIS.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Gilead Sciences (GIS.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Gilead Sciences (GIS.DE), currently trading at €99.72, will... Sign up to access price prediction.

About GIS.DE

LSE
  • Gilead Sciences, Inc.

  • Symbol

    GIS.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - General

  • Market Cap

    123.7B

Similar Stocks

PFE.F Pfizer Inc.
PFE.F
€20.42
3.5%
4
AMG.DE Amgen Inc.
AMG.DE
€238.2
0.7%
6
ZEG.DE AstraZeneca PLC
ZEG.DE
€136.6
1.3%
6
PFE.DE Pfizer Inc.
PFE.DE
€20.9
1.1%
5
IDP.DE Biogen Inc.
IDP.DE
€126.5
1.9%
7

GIS.DE Alternative Data

Web Traffic

Gilead Sciences receives an estimated 651985 monthly visitors to gilead.com, which is down by -1% over the last month.

  • Web Traffic

    651985

  • Change from Previous Month

    1%

  • 3 Month Change

    5.9%

  • YoY Change

    5.9%

Twitter Followers

Gilead Sciences has 72,995 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.

  • Twitter Followers

    72995

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Facebook Engagement

Gilead Sciences has engaged 49 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    49

  • Daily Change

    14%

  • 1 Month Change

    96%

  • 3 Month Change

    58.5%

  • YoY Change

    58.5%

Instagram Followers

Gilead Sciences has 15,713 Instagram Followers on its main Instagram account, up by 2.6% over the last month.

  • Instagram Followers

    15713

  • Daily Change

    0.2%

  • 1 Month Change

    2.6%

  • 3 Month Change

    9.7%

  • YoY Change

    9.7%

Youtube Subscribers

Gilead Sciences has 5,880 subscribers on its main Youtube channel, up by 0.7% over the last month.

  • Youtube Subscribers

    5880

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    2.1%

  • YoY Change

    2.1%

Job Postings

Gilead Sciences currenly has an estimated 330 open job postings, up by 11.5% over the last month.

  • Job Postings

    330

  • Daily Change

    1.8%

  • 1 Month Change

    11.5%

  • 3 Month Change

    11.5%

  • YoY Change

    11.5%

Reddit Mentions

Gilead Sciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

727,078 are following Gilead Sciences on LinkedIn, up by 1.6% over the last month.

  • LinkedIn Followers

    727078

  • Daily Change

    1.6%

  • 1 Month Change

    1.6%

  • 3 Month Change

    4.6%

  • YoY Change

    4.6%

Business Outlook

According to employee reviews, the business outlook among employees at Gilead Sciences is 54 out of 100 (neutral), up by 1.9% over the last month.

  • Business Outlook

    54

  • Change from Previous Month

    1.9%

  • 3 Month Change

    3.8%

  • YoY Change

    3.8%

LinkedIn Employees

According to LinkedIn, Gilead Sciences has 14,637 employees, down by -0.1% over the last month.

  • LinkedIn Employees

    14637

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

News Mentions

Gilead Sciences was mentioned 8 times in the news yesterday.

  • News Mentions

    8

  • Daily Change

    60%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

GIS.DE Financials

GIS.DE Key Metrics
  • Total Revenue

    $0

  • Net Income

    $0

  • Earnings per Share

    $1.06

  • Free cash flow

    $2.8B

  • EBITDA

    $0

  • EBITDA Ratio

    0

  • Total Assets

    $59B

GIS.DE 2-year Revenue & Income
GIS.DE 2-year Free Cash Flow

GIS.DE Technicals

GIS.DE SMA
GIS.DE RSI

FAQ

What's the current price of Gilead Sciences (GIS.DE) Stock?
The price of an Gilead Sciences (GIS.DE) share is €99.72.

What's the market cap of Gilead Sciences?
The current market cap of Gilead Sciences is 123.7B.

What are some stocks similar to Gilead Sciences (GIS.DE) that investors often compare it to?
Gilead Sciences (GIS.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., AstraZeneca PLC, Pfizer Inc. and Biogen Inc..

What is the forecast for Gilead Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Gilead Sciences' stock price to be around €105.3 in 2026. Starting from the current price of €99.72, this represents a 5.6% change in price, indicating a bullish outlook for the stock.

How to buy Gilead Sciences (GIS.DE) Stock?
Gilead Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Gilead Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.